By Professor David Thomas

Journal articles

Krebs MG; Malapelle U; André F; Paz-Ares L; Schuler M; Thomas DM; Vainer G; Yoshino T; Rolfo C, 2022, 'Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients with Cancer: A Narrative Review', JAMA Oncology, 8, pp. 1830 - 1839, http://dx.doi.org/10.1001/jamaoncol.2022.4457

Siu DHW; Ali A; Tjokrowidjaja A; De Silva M; Lee J; Clingan PR; Aghmesheh M; Brungs D; Mapagu C; Goldstein D; O'Neill S; Liauw WS; Sjoquist KM; Thomas D; Pavlakis N; Clarke SJ; Diakos C; Chantrill LA, 2022, 'Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers', Asia Pacific Journal of Clinical Oncology, 18, pp. 660 - 668, http://dx.doi.org/10.1111/ajco.13745

Gounder MM; Agaram NP; Trabucco SE; Robinson V; Ferraro RA; Millis SZ; Krishnan A; Lee J; Attia S; Abida W; Drilon A; Chi P; Angelo SPD; Dickson MA; Keohan ML; Kelly CM; Agulnik M; Chawla SP; Choy E; Chugh R; Meyer CF; Myer PA; Moore JL; Okimoto RA; Pollock RE; Ravi V; Singh AS; Somaiah N; Wagner AJ; Healey JH; Frampton GM; Venstrom JM; Ross JS; Ladanyi M; Singer S; Brennan MF; Schwartz GK; Lazar AJ; Thomas DM; Maki RG; Tap WD; Ali SM; Jin DX, 2022, 'Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma', Nature Communications, 13, http://dx.doi.org/10.1038/s41467-022-30496-0

Stacchiotti S; Maria Frezza A; Demetri GD; Blay JY; Bajpai J; Baldi GG; Baldini EH; Benjamin RS; Bonvalot S; Bovée JVMG; Callegaro D; Casali PG; D'Angelo SP; Davis EJ; Dei Tos AP; Demicco EG; Desai J; Dileo P; Eriksson M; Gelderblom H; George S; Gladdy RA; Gounder MM; Gupta AA; Haas R; Hayes A; Hohenberger P; Jones KB; Jones RL; Kasper B; Kawai A; Kirsch DG; Kleinerman ES; Le Cesne A; Maestro R; Martin Broto J; Maki RG; Miah AB; Palmerini E; Patel SR; Raut CP; Razak ARA; Reed DR; Rutkowski P; Sanfilippo RG; Sbaraglia M; Schaefer IM; Strauss DC; Strauss SJ; Tap WD; Thomas DM; Trama A; Trent JC; van der Graaf WTA; van Houdt WJ; von Mehren M; Wilky BA; Fletcher CDM; Gronchi A; Miceli R; Wagner AJ, 2022, 'Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments', Cancer Treatment Reviews, 110, http://dx.doi.org/10.1016/j.ctrv.2022.102455

Husereau D; Steuten L; Muthu V; Thomas DM; Spinner DS; Ivany C; Mengel M; Sheffield B; Yip S; Jacobs P; Sullivan T, 2022, 'Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?', Healthcare Switzerland, 10, http://dx.doi.org/10.3390/healthcare10102086

Best MC; Bartley N; Napier CE; Fisher A; Ballinger ML; Thomas DM; Goldstein D; Tucker K; Biesecker BB; Butow P, 2022, 'Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study', Supportive Care in Cancer, 30, pp. 8201 - 8210, http://dx.doi.org/10.1007/s00520-022-07272-3

Jadhao S; Davison C; Roulis EV; Lee S; Lacaze P; Riaz M; McNeil JJ; Thomas DM; Pecheniuk NM; Hyland CA; Flower RL; Nagaraj SH, 2022, 'Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians', Blood Advances, 6, pp. 4593 - 4604, http://dx.doi.org/10.1182/bloodadvances.2022007505

Best MC; Butow P; Savard J; Jacobs C; Bartley N; Davies G; Napier CE; Ballinger ML; Thomas DM; Biesecker B; Tucker KM; Juraskova I; Meiser B; Schlub T; Newson AJ, 2022, 'Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting', European Journal of Human Genetics, 30, pp. 930 - 937, http://dx.doi.org/10.1038/s41431-022-01069-y

Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM, 2022, 'Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients', Patient Education and Counseling, 105, pp. 2206 - 2216, http://dx.doi.org/10.1016/j.pec.2022.01.011

Tarride JE; Gould T; Thomas DM, 2022, 'Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling', International Journal of Technology Assessment in Health Care, 38, http://dx.doi.org/10.1017/S026646232200040X

Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Best MC, 2022, 'Psychological predictors of cancer patients' and their relatives’ attitudes towards the return of genomic sequencing results', European Journal of Medical Genetics, 65, http://dx.doi.org/10.1016/j.ejmg.2022.104516

Thomas DM; Hackett JM; Plestina S, 2022, 'Unlocking Access to Broad Molecular Profiling: Benefits, Barriers, and Policy Solutions', Public Health Genomics, 25, pp. 70 - 79, http://dx.doi.org/10.1159/000520000

Lau LMS; Mayoh C; Xie J; Barahona P; MacKenzie KL; Wong M; Kamili A; Tsoli M; Failes TW; Kumar A; Mould EVA; Gifford A; Chow SO; Pinese M; Fletcher JI; Arndt GM; Khuong-Quang DA; Wadham C; Batey D; Eden G; Trebilcock P; Joshi S; Alfred S; Gopalakrishnan A; Khan A; Grebert Wade D; Strong PA; Manouvrier E; Morgan LT; Span M; Lim JY; Cadiz R; Ung C; Thomas DM; Tucker KM; Warby M; McCowage GB; Dalla-Pozza L; Byrne JA; Saletta F; Fellowes A; Fox SB; Norris MD; Tyrrell V; Trahair TN; Lock RB; Cowley MJ; Ekert PG; Haber M; Ziegler DS; Marshall GM; Trahair T, 2022, 'In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer', EMBO Molecular Medicine, 14, pp. emmm202114608, http://dx.doi.org/10.15252/emmm.202114608

Lacaze PA; Tiller J; Winship I; Brotchie A; McNeil J; Zalcberg J; Thomas D; Milne R; James P; Delatycki M; Young MA; Nowak K; Nguyen-Dumont T; Southey M; Ademi Z; Bruinsma F; Riaz M; Terrill B; Kirk J; Tucker K; Andrews L; Pachter N; Susman R; Poplawski N; Wallis M; Watts G; Nicholls S; Macrae F; Sturm A; Green R; Ahern S; Revote J; Von Saldern S; Powell S; Rice T, 2022, 'Population DNA screening for medically actionable disease risk in adults', Medical Journal of Australia, 216, pp. 278 - 280, http://dx.doi.org/10.5694/mja2.51454

Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E, 2022, 'Delivering precision oncology to patients with cancer', Nature Medicine, 28, pp. 658 - 665, http://dx.doi.org/10.1038/s41591-022-01717-2

Napier CE; Davies G; Butow PN; Schlub TE; Best MC; Bartley N; Juraskova I; Meiser B; Tucker KM; Biesecker BB; Thomas DM; Ballinger ML, 2022, 'Cancer patient knowledge about and behavioral intentions after germline genome sequencing', Patient Education and Counseling, 105, pp. 707 - 718, http://dx.doi.org/10.1016/j.pec.2021.07.004

Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC; Young M-A, 2022, 'Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling', American Journal of Medical Genetics Part A, 188, pp. 725 - 734, http://dx.doi.org/10.1002/ajmg.a.62563

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2022, 'Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients', Patient Education and Counseling, 105, pp. 452 - 459, http://dx.doi.org/10.1016/j.pec.2021.05.018

Sylvester DE; Chen Y; Grima N; Saletta F; Padhye B; Bennetts B; Wright D; Krivanek M; Graf N; Zhou L; Catchpoole D; Kirk J; Latchoumanin O; Qiao L; Ballinger M; Thomas D; Jamieson R; Dalla-Pozza L; Byrne JA, 2022, 'Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer', Genes Chromosomes and Cancer, 61, pp. 81 - 93, http://dx.doi.org/10.1002/gcc.23006

Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC, 2022, 'Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study', Journal of Genetic Counseling, 31, pp. 96 - 108, http://dx.doi.org/10.1002/jgc4.1455

Thavaneswaran S; Chan WY; Asghari R; Grady JP; Deegan M; Jansen VM; Thomas DM, 2022, 'Clinical Response to Seribantumab, an Anti-Human Epidermal Growth Factor Receptor-3 Immunoglobulin 2 Monoclonal Antibody, in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma Harboring an NRG1 Fusion', JCO PRECISION ONCOLOGY, 6, http://dx.doi.org/10.1200/PO.22.00263

Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2022, 'Psychological Outcomes in Advanced Cancer Patients After Receiving Genomic Tumor Profiling Results', Health Psychology, 41, pp. 396 - 408, http://dx.doi.org/10.1037/hea0001181

Minoche AE; Lundie B; Peters GB; Ohnesorg T; Pinese M; Thomas DM; Zankl A; Roscioli T; Schonrock N; Kummerfeld S; Burnett L; Dinger ME; Cowley MJ, 2021, 'ClinSV: clinical grade structural and copy number variant detection from whole genome sequencing data', Genome Medicine, 13, pp. 32, http://dx.doi.org/10.1186/s13073-021-00841-x

Lin FP; Thavaneswaran S; Grady JP; Ballinger M; Kansara M; Oakes SR; Desai J; Lee CK; Simes J; Thomas DM, 2021, 'Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology', Npj Precision Oncology, 5, pp. 58, http://dx.doi.org/10.1038/s41698-021-00194-z

Gong B; Li D; Kusko R; Novoradovskaya N; Zhang Y; Wang S; Pabón-Peña C; Zhang Z; Lai K; Cai W; LoCoco JS; Lader E; Richmond TA; Mittal VK; Liu LC; Johann DJ; Willey JC; Bushel PR; Yu Y; Xu C; Chen G; Burgess D; Cawley S; Giorda K; Haseley N; Qiu F; Wilkins K; Arib H; Attwooll C; Babson K; Bao L; Bao W; Lucas AB; Best H; Bhandari A; Bisgin H; Blackburn J; Blomquist TM; Boardman L; Burgher B; Butler DJ; Chang CJ; Chaubey A; Chen T; Chierici M; Chin CR; Close D; Conroy J; Coleman JC; Craig DJ; Crawford E; del Pozo A; Deveson IW; Duncan D; Eterovic AK; Fan X; Foox J; Furlanello C; Ghosal A; Glenn S; Guan M; Haag C; Hang X; Happe S; Hennigan B; Hipp J; Hong H; Horvath K; Hu J; Hung LY; Jarosz M; Kerkhof J; Kipp B; Kreil DP; Łabaj P; Lapunzina P; Li P; Li QZ; Li W; Li Z; Liang Y; Liu S; Liu Z; Ma C; Marella N; Martín-Arenas R; Megherbi DB; Meng Q; Mieczkowski PA; Morrison T; Muzny D; Ning B; Parsons BL; Paweletz CP; Pirooznia M; Qu W; Raymond A; Rindler P; Ringler R; Sadikovic B; Mercer T; Thomas D, 2021, 'Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions', Genome Biology, 22, pp. 109, http://dx.doi.org/10.1186/s13059-021-02315-0

Bartley N; Davies G; Butow P; Napier CE; Schlub T; Ballinger ML; Thomas DM; Juraskova I; Meiser B; Best MC, 2021, 'Fear of cancer recurrence in patients undergoing germline genome sequencing', Supportive Care in Cancer, 29, pp. 7289 - 7297, http://dx.doi.org/10.1007/s00520-021-06311-9

Cilento MA; Poplawski NK; Paramasivam S; Thomas DM; Kichenadasse G, 2021, 'Germline PALB2 variants and PARP inhibitors in endometrial cancer', Jnccn Journal of the National Comprehensive Cancer Network, 19, pp. 1212 - 1217, http://dx.doi.org/10.6004/jnccn.2021.7067

Butow P; Müller F; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub TE; Thomas DM; Goldstein D; Best MC; Newson A; Tucker K; Vines R; Vines K; Kirk J; Young MA; Savard J; Jacobs C, 2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho Oncology, 30, pp. 1920 - 1929, http://dx.doi.org/10.1002/pon.5764

Singhal D; Hahn CN; Feurstein S; Wee LYA; Moma L; Kutyna MM; Chhetri R; Eshraghi L; Schreiber AW; Feng J; Wang PPS; Babic M; Parker WT; Gao S; Moore S; Das S; Thomas D; Pattnaik S; Brown AL; D’Andrea RJ; Poplawski NK; Thomas D; Scott HS; Godley LA; Hiwase DK, 2021, 'Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer', Leukemia, 35, pp. 3245 - 3256, http://dx.doi.org/10.1038/s41375-021-01246-w

Thavaneswaran S; Ballinger M; Butow P; Meiser B; Goldstein D; Lin F; Napier C; Thomas D; Best M, 2021, 'The experiences and needs of australian medical oncologists in integrating comprehensive genomic profiling into clinical care: A nation-wide survey', Oncotarget, 12, pp. 2169 - 2176, http://dx.doi.org/10.18632/ONCOTARGET.28076

Stacchiotti S; Frezza AM; Blay JY; Baldini EH; Bonvalot S; Bovée JVMG; Callegaro D; Casali PG; Chiang RRCJ; Demetri GD; Demicco EG; Desai J; Eriksson M; Gelderblom H; George S; Gounder MM; Gronchi A; Gupta A; Haas RL; Hayes-Jardon A; Hohenberger P; Jones KB; Jones RL; Kasper B; Kawai A; Kirsch DG; Kleinerman ES; Le Cesne A; Lim J; Chirlaque López MD; Maestro R; Marcos-Gragera R; Martin Broto J; Matsuda T; Mir O; Patel SR; Raut CP; Razak ARA; Reed DR; Rutkowski P; Sanfilippo RG; Sbaraglia M; Schaefer IM; Strauss DC; Sundby Hall K; Tap WD; Thomas DM; van der Graaf WTA; van Houdt WJ; Visser O; von Mehren M; Wagner AJ; Wilky BA; Won YJ; Fletcher CDM; Dei Tos AP; Trama A, 2021, 'Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities', Cancer, 127, pp. 2934 - 2942, http://dx.doi.org/10.1002/cncr.33618

Vatter S; Bartley N; Best M; Juraskova I; Jacobs C; Ballinger ML; Thomas DM; Butow P, 2021, 'Does undertaking genome sequencing prompt actual and planned lifestyle-related behavior change in cancer patients and survivors? A qualitative study', Journal of Psychosocial Oncology Research and Practice, 3, pp. E059, http://dx.doi.org/10.1097/OR9.0000000000000059

Willis AM; Smith SK; Meiser B; James PA; Ballinger ML; Thomas DM; Yanes T; Young MA, 2021, 'Influence of lived experience on risk perception among women who received a breast cancer polygenic risk score: ‘Another piece of the pie’', Journal of Genetic Counseling, 30, pp. 849 - 860, http://dx.doi.org/10.1002/jgc4.1384

Smit AK; Bartley N; Best MC; Napier CE; Butow P; Newson AJ; Tucker K; Ballinger ML; Thomas DM; Jacobs C; Meiser B; Goldstein D; Savard J; Juraskova I, 2021, 'Family communication about genomic sequencing: A qualitative study with cancer patients and relatives', Patient Education and Counseling, 104, pp. 944 - 952, http://dx.doi.org/10.1016/j.pec.2020.10.022

Scheinberg T; Lomax A; Tattersall M; Thomas D; McCowage G; Sullivan M; Karim R; Luk PP; Mahar A; Bonar F; Bhadri VA, 2021, 'PD-1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma', Cancer Reports, 4, http://dx.doi.org/10.1002/cnr2.1327

Kovac M; Woolley C; Ribi S; Blattmann C; Roth E; Morini M; Kovacova M; Ameline B; Kulozik A; Bielack S; Hartmann W; Ballinger ML; Thomas DM; Tomlinson I; Nathrath M; Heinimann K; Baumhoer D, 2021, 'Germline RET variants underlie a subset of paediatric osteosarcoma', Journal of Medical Genetics, 58, pp. 20 - 24, http://dx.doi.org/10.1136/jmedgenet-2019-106734

Mweempwa A; Xu H; Vissers JHA; Tothill RW; Pattison AD; Fellowes AP; Thomas DM; Richardson G; Hicks RJ; Grimmond SM; Fox SB; Luen SJ; Desai J; Solomon BJ, 2021, 'Novel RET fusion RET-SEPTIN9 predicts response to selective RET inhibition with selpercatinib in malignant pheochromocytoma', JCO Precision Oncology, 5, pp. 1160 - 1165, http://dx.doi.org/10.1200/PO.21.00127

Alcindor T; Dumitra S; Albritton K; Thomas DM, 2021, 'Disparities in Cancer Care: The Example of Sarcoma-In Search of Solutions for a Global Issue.', Am Soc Clin Oncol Educ Book, 41, pp. 1 - 7, http://dx.doi.org/10.1200/EDBK_320463

Ballinger ML; Thomas D, 2021, 'Heritable cancer risk in the genomic ERA', Pathology, 53, pp. S10 - S10, http://dx.doi.org/10.1016/j.pathol.2021.05.038

Kaur S; Sikta N; Schafferhans A; Bordin N; Cowley M; Thomas D; Ballinger M; O’Donoghue S, 2021, 'Streamlined use of protein structures in variant analysis', , http://dx.doi.org/10.1101/2021.09.10.459756

Heyer EE; Deveson IW; Wooi D; Selinger CI; Lyons RJ; Hayes VM; O’Toole SA; Ballinger ML; Gill D; Thomas DM; Mercer TR; Blackburn J; O'Toole S, 2020, 'Author Correction: Diagnosis of fusion genes using targeted RNA sequencing (Nature Communications, (2019), 10, 1, (1388), 10.1038/s41467-019-09374-9)', Nature Communications, 11, pp. 1810, http://dx.doi.org/10.1038/s41467-020-15697-9

Kalachand RD; Stordal B; Madden S; Chandler B; Cunningham J; Goode EL; Ruscito I; Braicu EI; Sehouli J; Ignatov A; Yu H; Katsaros D; Mills GB; Lu KH; Carey MS; Timms KM; Kupryjanczyk J; Rzepecka IK; Podgorska A; McAlpine JN; Swisher EM; Bernards SS; O'Riain C; O'Toole S; O'Leary JJ; Bowtell DD; Thomas DM; Prieske K; Joosse SA; Woelber L; Chaudhry P; Häfner N; Runnebaum IB; Hennessy BT, 2020, 'BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis', Journal of the National Cancer Institute, 112, pp. 1190 - 1203, http://dx.doi.org/10.1093/jnci/djaa070

Pinese M; Lacaze P; Rath EM; Stone A; Brion MJ; Ameur A; Nagpal S; Puttick C; Husson S; Degrave D; Cristina TN; Kahl VFS; Statham AL; Woods RL; McNeil JJ; Riaz M; Barr M; Nelson MR; Reid CM; Murray AM; Shah RC; Wolfe R; Atkins JR; Fitzsimmons C; Cairns HM; Green MJ; Carr VJ; Cowley MJ; Pickett HA; James PA; Powell JE; Kaplan W; Gibson G; Gyllensten U; Cairns MJ; McNamara M; Dinger ME; Thomas DM, 2020, 'The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly', Nature Communications, 11, pp. 435, http://dx.doi.org/10.1038/s41467-019-14079-0

Demetri GD; Antonescu CR; Bjerkehagen B; Bovée JVMG; Boye K; Chacón M; Dei Tos AP; Desai J; Fletcher JA; Gelderblom H; George S; Gronchi A; Haas RL; Hindi N; Hohenberger P; Joensuu H; Jones RL; Judson I; Kang YK; Kawai A; Lazar AJ; Le Cesne A; Maestro R; Maki RG; Martín J; Patel S; Penault-Llorca F; Premanand Raut C; Rutkowski P; Safwat A; Sbaraglia M; Schaefer IM; Shen L; Serrano C; Schöffski P; Stacchiotti S; Sundby Hall K; Tap WD; Thomas DM; Trent J; Valverde C; van der Graaf WTA; von Mehren M; Wagner A; Wardelmann E; Naito Y; Zalcberg J; Blay JY, 2020, 'Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network', Annals of Oncology, 31, pp. 1506 - 1517, http://dx.doi.org/10.1016/j.annonc.2020.08.2232

Wong M; Mayoh C; Lau LMS; Khuong-Quang DA; Pinese M; Kumar A; Barahona P; Wilkie EE; Sullivan P; Bowen-James R; Syed M; Martincorena I; Abascal F; Sherstyuk A; Bolanos NA; Baber J; Priestley P; Dolman MEM; Fleuren EDG; Gauthier ME; Mould EVA; Gayevskiy V; Gifford AJ; Grebert-Wade D; Strong PA; Manouvrier E; Warby M; Thomas DM; Kirk J; Tucker K; O’Brien T; Alvaro F; McCowage GB; Dalla-Pozza L; Gottardo NG; Tapp H; Wood P; Khaw SL; Hansford JR; Moore AS; Norris MD; Trahair TN; Lock RB; Tyrrell V; Haber M; Marshall GM; Ziegler DS; Ekert PG; Cowley MJ; O'Brien T; Wong-Erasmus M, 2020, 'Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer', Nature Medicine, 26, pp. 1742 - 1753, http://dx.doi.org/10.1038/s41591-020-1072-4

Bartley N; Best M; Jacobs C; Juraskova I; Newson AJ; Savard J; Meiser B; Ballinger ML; Thomas DM; Biesecker B; Butow P, 2020, 'Cancer patients' views and understanding of genome sequencing: A qualitative study', Journal of Medical Genetics, 57, pp. 671 - 676, http://dx.doi.org/10.1136/jmedgenet-2019-106410

Davies G; Butow P; Napier CE; Bartley N; Juraskova I; Meiser B; Ballinger ML; Thomas DM; Schlub TE; Best MC, 2020, 'Advanced Cancer Patient Knowledge of and Attitudes towards Tumor Molecular Profiling', Translational Oncology, 13, pp. 100799, http://dx.doi.org/10.1016/j.tranon.2020.100799

Lim LE; Chan DL; Thomas D; Du Y; Tincknell G; Kuchel A; Davis A; Bailey DL; Pavlakis N; Cehic G; Macdonald W; Wyld D; Segelov E, 2020, 'Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours', Oncotarget, 11, pp. 2636 - 2646, http://dx.doi.org/10.18632/oncotarget.27659

Joshua AM; Prawira A; Thavaneswaran S; Cosman R; Lee CK; Sjoquist KM; Simes J; Thomas DM; Espinoza D; Sebastian L; Ballinger ML; Hague W; Chinchen S; Collignon E; Kansara M; Palacios T; Grady J; Barker H; Thornton K, 2020, 'A signal-seeking trial of olaparib and durvalumab in homologous repair-deficient tumors: A sub-study of the cancer molecular screening and therapeutics (MoST) program.', Journal of Clinical Oncology, 38, pp. 3073 - 3073, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.3073

Zaheed M; Tucker K; Ballinger ML; Thomas DM, 2020, 'Genotype and phenotype correlation of common cancer predisposition syndromes in sarcoma cases.', Journal of Clinical Oncology, 38, pp. 1524 - 1524, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1524

Back to profile page